Walleye Trading LLC Vericel Corp Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $227,976 - $327,522	-4,830 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $149,391 - $287,288	4,830 New	4,830 $268,000
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $61,389 - $105,108	-5,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $51,870 - $84,360	5,700 New	5,700 $81,000
Q4 2017 Feb 14, 2018	SELL	$3.65 - $5.98 $166,805 - $273,286	-45,700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.0 - $6.0 $137,100 - $274,200	45,700	45,700 $274,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.